Satellite Symposia
Satellite Symposia Schedule
Satellite Symposia Schedule
Thank you for registering for the 2025 Crohn’s & Colitis Congress®. While you’re at the Congress, you can take advantage of any of the following satellite symposia. Please be sure to register for each one separately.
Thursday, February 6, 2025
IBD, IL-23, and Inflammation, Oh My! Following the Yellow Brick Road in Using IL-23 Targeted Therapies in Managing IBD
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Faculty
- Corey A. Siegel, MD, MS (Moderator)
- Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE, FCCF
- Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN
- Uma Mahadevan, MD
In this CME Outfitters symposium, expert faculty will instruct learners on the role of pro-inflammatory cytokines in the pathogenesis of IBD. Learners will be guided on the role of the IL-23/Th17 inflammatory axis in IBD pathogenesis and how to appraise the clinical implications of anti-IL-23 agents used in the treatment of IBD. Faculty will model the development of individualized treatment plans for patients with IBD that are eligible for treatment with an IL-23-targeted agent.
Here Come the IL-23p19 Inhibitors: Exploring New Treatments in IBD
In partnership with Lilly, USA.
Join expert faculty, Prof. Vipul Jairath and Dr. Aline Charabaty, as they explore the new and evolving treatment landscape in inflammatory bowel disease (IBD) during interactive, patient case-based discussions.
Learning Objectives:
- Examine the evolving treatment goals in the management of IBD
- Interpret the efficacy and safety, including the long-term data for IL-23p19 inhibitors
- Apply these concepts in case discussions
Faculty
- Prof. Vipul Jairath
- Dr. Aline Charabat
Friday, February 7, 2025
Updates in TNF-alpa inhibitors for Inflammatory Bowel Disease and new modes of delivery for patient centered care
In partnership with Celltrion USA Medical Affairs.
Faculty
- Jessica R. Allegretti, MD, MPH, FACG, AGAF
Despite advances in IBD treatments, TNF alpha inhibitors remain the mainstay in patient care. Subcutaneous Infliximab offers an alternative method of delivery and simplifies patient care. This session will discuss one- and two-year clinical data for Infliximab-dyyb SC injection, as well as the importance of steady, stable serum drug levels in the patient treatment journey.
Arm in Arm With Crohn’s Disease Experts: A Master Class in Noninvasive Imaging and Histologic Endpoints
Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the American Gastroenterological Association (AGA). This activity is supported by an educational grant from Lilly.
Faculty
- Jordan Axelrad, MD, MPH, FACG
- Russell D. Cohen, MD, FACG, AGAF
- Marla Dubinsky, MD
- Amy Stewart, MSN, FNP-C
- Ryan Ungaro, MD, MS
The goal of this activity is to improve knowledge, competence, and performance among GI HCP learners on treat-to-target strategies in CD, noninvasive imaging, and the newest treatment targets, including histological endpoints, to optimize and individualize patient care.
Host an Educational Program
Satellite Symposia provides your organization with a unique opportunity to host educational programs before or after Crohn’s & Colitis Congress scientific sessions, often offering CME credit to participants. A limited number of symposia will be permitted so be sure to reserve yours today. Crohn’s & Colitis Congress Council policy prohibits Satellite Symposia during scheduled scientific sessions.
| Timeline | Date |
|---|---|
| Application goes live on website | Sept. 19, 2024 |
Guidelines (link to pdf )
Available Dates & Times
| Dates | Morning Slots | Evening Slots |
|---|---|---|
| Thurs., Feb. 6 | n/a | 2 |
| Fri., Feb. 7 | 2 | n/a |
| Sat., Feb. 8 | 1 | n/a |
Fees
| Time Slot | Slot Fee |
|---|---|
| AM Symposium | $30,000 |
| PM Symposium | $30,000 |
Application and Deadlines
There is no application deadline; however, slots are assigned based on receipt of full payment. We can accept applications until all the slots are full.
For more information, please get in touch with Emily Glass, eglass@gastro.org
